| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_75e25d006354e9ec20283b5e6624995d |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4709
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4709
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate |
2021-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ca5bbe6056cc69998ab51551d2915971
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1020f82794448438553fc340402c1989
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a6f1473f6f8034909e73c9a41cb7cb3b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7342e9b47064658a5a4f37159d095f05 |
| publicationDate |
2022-05-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-114469949-A |
| titleOfInvention |
Quinoline derivatives for the treatment of diffuse large B-cell lymphoma |
| abstract |
The present application belongs to the technical field of medicine, and relates to the use of quinoline derivatives for anti-tumor. Specifically, the present application relates to a quinoline derivative represented by compound I for the treatment of diffuse large B-cell lymphoma, its pharmaceutical composition in combination with a second therapeutic drug, and its use in the treatment of diffuse large B-cell lymphoma use. Wherein, the chemical name of compound 1 is 1-[[[4-(4-fluoro-2-methyl-1H-indol-5-yl)oxy-6-methoxyquinoline-7-yl]oxygen base]methyl]cyclopropylamine. |
| priorityDate |
2020-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |